Table 1 Patients characteristics, N = 100
From: Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Characteristics | Number (%) |
|---|---|
Age | |
Median (years) | 40 |
Range (years) | 22–75 |
Pathology | |
IDC | 91 (91%) |
ILC and others | 9 (9%) |
Stage | |
I | 16 (16%) |
II | 51 (51%) |
III | 22 (22%) |
IV | 2 (2%) |
Unknown | 9 (9%) |
Grade | |
I | 10 (10%) |
II | 37 (37%) |
III | 45 (45%) |
Unknown | 8 (8%) |
Hormone Receptor Status | |
ER and/or PR Positive | 77 (77%) |
ER Positive | 77 (77%) |
ER Negative | 22 (22%) |
ER Unknown | 1 (1%) |
PR Positive | 77 (77%) |
PR Negative | 22 (22%) |
PR Unknown | 1 (1%) |
HER-2 Status | |
Positive | 13 (13%) |
Negative | 80 (80%) |
Unknown | 7 (7%) |
Triple-Negative | 17 (17%) |